Navigation Links
2 Cleveland Clinic researchers honored for contribution to science
Date:11/25/2013

Monday, Nov. 25, 2013, Cleveland: Cleveland Clinic researchers Richard A. Padgett, Ph.D., and Edward F. Plow, Ph.D., have been named Fellows of the American Association for the Advancement of Science (AAAS). This year's AAAS Fellows will be formally announced in the AAAS News & Notes section of the journal Science on Nov. 29, 2013.

Dr. Padgett, who works in the Department of Molecular Genetics at the Lerner Research Institute, was elected as an AAAS Fellow for distinguished contributions to the field of RNA processing, particularly in the areas of RNA splicing, the diversity of splicing mechanisms, and connections with disease.

RNA, or ribonucleic acid, is a nucleic acid present in all living cells that translates the genetic code (DNA) into proteins. RNA splicing is the processing of RNA to remove portions that do not encode proteins. Many diseases are either caused by or associated with mistakes in the splicing process or mutations in the splicing machinery. Dr. Padgett's research aims to understand how these errors in RNA splicing lead to disease, such as cancer, and how the errors can be corrected.

Dr. Plow, Department Chair of Molecular Cardiology at the Lerner Research Institute, and The Robert C. Tarazi, M.D., Endowed Chair in Heart and Hypertension Research, is being honored as an AAAS Fellow for distinguished contributions to vascular biology, particularly for elucidating mechanisms of platelets, integrins, and plasminogen, and outstanding services to the cardiovascular community.

Dr. Plow's research involves dissecting the cellular mechanisms underlying hypertension and heart disease. Specifically, he studies the role of integrins, a type of cell adhesion molecule involved in blood coagulation, in cardiovascular disease. He also recently discovered that the blood protein plasminogen, which has long been associated with coronary artery disease, and a related enzyme are essential in the formation of foam cells-- a hallmark of advanced atherosclerosis, or hardening of the arteries.

Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers. This year 388 members have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to advance science or its applications.


'/>"/>

Contact: Laura Ambro
ambrol@ccf.org
216-636-5876
Cleveland Clinic
Source:Eurekalert

Related biology news :

1. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
2. Cleveland Clinic develops clinical screening program for no.1 genetic cause of colon cancer
3. Cleveland Clinic research shows anemia drug does not improve health of anemic heart failure patients
4. Cleveland Clinic researchers discover new link between heart disease and red meat
5. Cleveland Clinic research shows gut bacteria byproduct predicts heart attack and stroke
6. Cleveland Clinics 2013 Obesity Summit explores causes, prevention and treatment of obesity
7. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
8. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
9. New clinical trial explores novel noninvasive colon cancer screening test
10. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
11. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology: